DrugPatentWatch Database Preview

VELTASSA Drug Profile

« Back to Dashboard

When do Veltassa patents expire, and when can generic versions of Veltassa launch?

Veltassa is a drug marketed by Relypsa Inc and is included in one NDA. There are ten patents protecting this drug.

This drug has one hundred and thirty-eight patent family members in twenty-three countries.

The generic ingredient in VELTASSA is patiromer sorbitex calcium. One supplier is listed for this compound. Additional details are available on the patiromer sorbitex calcium profile page.

Summary for VELTASSA

International Patents:	138
US Patents:	10
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Clinical Trials:	9
Drug Prices:	see details
DailyMed Link:	VELTASSA at DailyMed

Pharmacology for VELTASSA

Drug Class	Potassium Binder
Mechanism of Action	Potassium Ion Binding Activity

US Patents and Regulatory Information for VELTASSA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Relypsa Inc	VELTASSA	patiromer sorbitex calcium	POWDER;ORAL	205739-003	Oct 21, 2015		RX	Yes	Yes			Y
Relypsa Inc	VELTASSA	patiromer sorbitex calcium	POWDER;ORAL	205739-003	Oct 21, 2015		RX	Yes	Yes
Relypsa Inc	VELTASSA	patiromer sorbitex calcium	POWDER;ORAL	205739-003	Oct 21, 2015		RX	Yes	Yes
Relypsa Inc	VELTASSA	patiromer sorbitex calcium	POWDER;ORAL	205739-003	Oct 21, 2015		RX	Yes	Yes

Non-Orange Book US Patents for VELTASSA

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
7,776,319	Methods and compositions for treatment of ion imbalances
7,854,924	Methods and compositions for treatment of ion imbalances
8,192,758	Ion binding compositions
7,429,394	Ion binding compositions

International Patents for VELTASSA

Country	Document Number	Estimated Expiration
San Marino	T201500207
United Kingdom	201222752
Lithuania	PA2018004
European Patent Office	2916851

Supplementary Protection Certificates for VELTASSA

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0924	Netherlands		PRODUCT NAME: PATIROMER EN ALLE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/17/1179/001-009 20170721
2018 00003	Denmark		PRODUCT NAME: PATIROMER AND ANY SALTS AND DERIVATIVES THEREOF; REG. NO/DATE: EU/1/17/1179 20170721
2018 00006	Denmark		PRODUCT NAME: PATIROMER SORBITEX CALCIUM AND ANY SALTS AND DERIVATIVES THEREOF; REG. NO/DATE: EU/1/17/1179/001-009 20170721
2018004	Lithuania		PRODUCT NAME: PATIROMERO, SORBITOLIO IR KALCIO KOMPLEKSAS IR JO DRUSKOS; REGISTRATION NO/DATE: EU/1/17/1179 20170719